CHICAGO–( SERVICE CABLE)– Tempus AI, Inc. (NASDAQ: TEM), a modern technology firm leading the fostering of AI to progress accuracy medication and individual treatment, today introduced the launch of its Fuses program. This campaign will certainly harness Tempus’ exclusive dataset to create important understandings for both individual treatment and research study, integrating the power of its information and artificial intelligence capacities to create an AI enabled-diagnostic system offering medical professionals the biggest collection of mathematical examinations desi
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/tempus-introduces-fuses-a-program-designed-to-transform-therapeutic-research-and-build-the-largest-diagnostic-platform-using-its-novel-foundation-model/
